Results 191 to 200 of about 53,515 (238)

One-Week Inflammatory Kinetics After First-Line Nivolumab Plus Ipilimumab in Metastatic Renal Cell Carcinoma: A Multicenter Landmark Analysis. [PDF]

open access: yesTarget Oncol
Inoue T   +17 more
europepmc   +1 more source

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma. [PDF]

open access: yesESMO Open
Kanesvaran R   +27 more
europepmc   +1 more source

Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma. [PDF]

open access: yesJ Immunother Cancer
McKay RR   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy